Skyward Specialty Insurance stock soars to all-time high of $63.84

Published 02/06/2025, 14:34
Skyward Specialty Insurance stock soars to all-time high of $63.84

Skyward Specialty Insurance Group Inc. (SKWD) has reached an impressive milestone, with its stock price climbing to an all-time high of $63.84. According to InvestingPro data, the company, now valued at $2.56 billion, shows a "GREAT" overall financial health score. This peak represents a significant achievement for the company, reflecting a robust performance and growing investor confidence. Over the past year, Skyward Specialty Insurance has witnessed a remarkable 69.75% increase in its stock value, supported by impressive 26.3% revenue growth and a P/E ratio of 20.07. The company’s strong market presence and ability to adapt are evident in its performance metrics, though InvestingPro analysis suggests the stock is currently trading above its Fair Value. Investors are closely monitoring SKWD as it continues to navigate the market with strategic agility, potentially setting the stage for further gains. Analyst price targets range from $43 to $72, with InvestingPro offering 8 additional key insights about the company’s future prospects in its comprehensive Pro Research Report.

In other recent news, Skyward Specialty Insurance Group reported impressive financial results for the first quarter of 2025, surpassing analyst expectations. The company achieved an earnings per share (EPS) of $0.90, significantly higher than the projected $0.68, while revenue reached $328.53 million, exceeding the forecasted $274.57 million. This marks the highest net income in the company’s history, with a notable increase in gross written premiums by 17%. Additionally, Keefe, Bruyette & Woods (KBW) raised its price target for Skyward Specialty Insurance from $67.00 to $72.00, maintaining an Outperform rating, citing strong reserve strengths. The firm’s earnings estimates for the upcoming years remain unchanged, reflecting confidence in Skyward’s continued growth and financial strategy.

In a strategic move, Skyward Specialty appointed Corey LaFlamme as President of Captives & Specialty Programs, while Kirby (NYSE:KEX) Hill transitioned to Chairman of the same divisions. This leadership change aims to enhance the company’s position in the specialty insurance market. Furthermore, during its Annual Meeting of Shareholders, the company elected new directors and ratified the appointment of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2025. These developments highlight Skyward Specialty’s ongoing efforts to strengthen its leadership and governance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.